Literature DB >> 6530052

Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables.

T A Welborn, M Knuiman, V McCann, K Stanton, I J Constable.   

Abstract

A cross-sectional study of 1084 Caucasoid diabetic subjects in rural Western Australia revealed a high rate of clinical macrovascular disease (46%), including coronary heart disease (13%), stroke (8%), and peripheral vascular disease (38%). Age was the major time-related variable for total macrovascular disease and for peripheral vascular disease, with identical prevalence rates in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes when age was taken into account. In 179 Type 1 diabetic subjects, logistic regression analysis showed no associated risk factors other than age. In 905 Type 2 diabetic subjects the independent risk factors for total macrovascular disease, identified by a forward step-wise selection procedure, were age as the major contributor, with plasma creatinine levels and plasma glucose levels (all p less than 0.001), high-density lipoprotein cholesterol levels, serum total cholesterol levels, and the (supine-erect) systolic blood pressure difference (all p less than 0.05). There were no direct associations with percentage desirable weight, cigarette smoking or male sex. Type 2 diabetic subjects demonstrated a very strong negative association between high-density lipoprotein cholesterol levels and coronary heart disease, and significant associations were found also between plasma glucose levels and coronary heart disease (p less than 0.01), and glycosylated haemoglobin levels and peripheral vascular disease (p less than 0.001).

Entities:  

Mesh:

Year:  1984        PMID: 6530052     DOI: 10.1007/bf00276969

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins].

Authors:  M BURSTEIN; J SAMAILLE
Journal:  Clin Chim Acta       Date:  1960-07       Impact factor: 3.786

2.  Atherosclerosis in persons with hypertension and diabetes mellitus.

Authors:  W B Robertson; J P Strong
Journal:  Lab Invest       Date:  1968-05       Impact factor: 5.662

3.  Blood glucose and coronary heart disease.

Authors:  E Eschwege; P Ducimetiere; L Papoz; J R Claude; J L Richard
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

4.  Epidemiologic methods in diabetic macrovascular disease.

Authors:  G Rose; H Keen; J Jarrett
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

5.  High density lipoproteins in diabetes.

Authors:  E A Nikkilä
Journal:  Diabetes       Date:  1981       Impact factor: 9.461

6.  A rapid simplified method for routine measurement of glycosylated haemoglobin.

Authors:  R E Davis; D J Nicol
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

7.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

8.  Assessing the risk of diabetic retinopathy.

Authors:  I J Constable; M W Knuiman; T A Welborn; R L Cooper; K M Stanton; V J McCann; G C Grose
Journal:  Am J Ophthalmol       Date:  1984-01       Impact factor: 5.258

9.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

10.  Cholesterol and lipoprotein-cholesterol levels in Western Australian rural diabetics.

Authors:  J R Masarei; I J Constable; K Stanton; R E Davis
Journal:  Aust N Z J Med       Date:  1982-08
View more
  9 in total

1.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

Review 2.  Peripheral arterial disease in diabetes: is there a role for genetics?

Authors:  Arabindra B Katwal; Ayotunde O Dokun
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

3.  Macrovascular disease in Caucasoid diabetic patients.

Authors:  T D Hockaday
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

4.  Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD.

Authors:  Ayotunde O Dokun; Lingdan Chen; Swapnil S Lanjewar; Robert John Lye; Brian H Annex
Journal:  Cardiovasc Res       Date:  2014-01-02       Impact factor: 10.787

Review 5.  Diabetic dyslipidaemia: current treatment recommendations.

Authors:  J D Best; D N O'Neal
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

6.  Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.

Authors:  M I Uusitupa; L K Niskanen; O Siitonen; E Voutilainen; K Pyörälä
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

7.  Genetic and metabolic risk factors for the development of late complications in type I (insulin-dependent) diabetes.

Authors:  A E Pontiroli; A Calderara; L Bonisolli; P Maffi; A De Pasqua; A Margonato; G Radaelli; G Gallus; G Pozza
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

Review 8.  The fourth musketeer--from Alexandre Dumas to Claude Bernard.

Authors:  G M Reaven
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

9.  Change in ankle-brachial index over time and mortality in diabetics with proteinuria.

Authors:  Sirin Jiwakanon; Sharon Adler; Rajnish Mehrotra
Journal:  Clin Nephrol       Date:  2012-11       Impact factor: 0.975

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.